Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable ...

A new material similar to that used by the U.S. Military to treat traumatic injuries is showing promise as the next novel treatment for bleeding ulcers, a condition that commonly affects up to 15 per ...

T&R Biofab announced on the 13th that it has received permission for domestic sales of a powder-type hemostatic agent product from the Ministry of Food and Drug Safety. This hemostatic agent is a ...

A hemostatic powder, TC-325 (Hemospray), worked as well as standard treatment for endoscopic control of acute bleeds from nonvariceal upper gastrointestinal lesions, a randomized trial found. In the ...

Please provide your email address to receive an email when new articles are posted on . A hemostatic powder applied during an upper endoscopy as an early intervention was effective for treating acute ...

SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Nextbiomedical announced today that its novel hemostatic powder, Nexpowder™, has been published in GUT (Impact Factor: 23), one of the world's most ...

Wilmington, Delaware, United States, Transparency Market Research, Inc. , Oct. 22, 2024 (GLOBE NEWSWIRE) -- The hemostatic agents industry (Industrie für blutstillende Mittel) was worth US$ 2.6 ...

Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products PERCLOT further enhances clinicians’ ability ...